Peginterferon alfa-2a biosimilar (Incepta Pharmaceuticals)

聚乙二醇化干扰素α2a生物类似药 (Incepta Pharmaceuticals)

Report date: 2022/02/11 13:23:54

Base Information

Drug NamePeginterferon alfa-2a biosimilar (Incepta Pharmaceuticals)
Drug Alias Name聚乙二醇化干扰素α2a生物仿制药 (Incepta Pharmaceuticals)Optipeg-A
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis CHepatitis B
Global Approved IndicationsHepatitis CHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryBangladesh
Original Approved Date2012/08/01
Country/TerritoryBangladesh
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesIncepta Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIncepta Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis CHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeL03AB11
Related LinksN/A